EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply

Peter A Dargaville, John B Carlin, Peter G Davis

JAMA · 2024

DOI: 10.1001/jama.2023.24533 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Peter A Dargaville und 2 weiteren Autor:innen. Beteiligte Einrichtung: Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. Hauptthemen laut MEDLINE: Infant, Premature, Pulmonary Surfactants, Surface-Active Agents. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant, PrematurePulmonary SurfactantsSurface-Active AgentsHumansInfantInfant, NewbornLipoproteinsTreatment Outcome

Substanzen

LipoproteinsPulmonary SurfactantsSurface-Active Agents

Autor:innen und Institutionen

  • Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Melbourne, Australia.
  • Neonatal Services, Royal Women's Hospital, Melbourne, Australia.

Zitieren

APA

Dargaville, P. A., Carlin, J. B., & Davis, P. G. (2024). Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply. JAMA. https://doi.org/10.1001/jama.2023.24533

Vancouver

Dargaville PA, Carlin JB, Davis PG. Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply. JAMA. 2024. doi:10.1001/jama.2023.24533

BibTeX
@article{Dargaville2024,
  author = {Dargaville, Peter A and Carlin, John B and Davis, Peter G},
  title = {Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2023.24533}
}
Kostenlos starten →